Clinical Trial Update: A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing whether clascoterone cream 1% reduces sebum production in patients with acne vulgaris; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Clascoterone cream 1% (clascoterone)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED